| CAS ID: | 183319-69-9 |
| Molecular Formula: | C22H24ClN3O4 |
| Molecular Weight: | 393.4 g/mol |
| Monoisotopic Mass: | 393.1689 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ERLOTINIB HYDROCHLORIDE | CP-358,774-01 | OSI-774 | TARCEVA | CP-358774-01 |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02273362 | Disease | Liver fibrosis |
| Phase | Phase 1,Phase 2 | Status | Recruiting |
| First Received | October 24, 2014 | Last Verified | February 27, 2019 |
| Sponsor | National Cancer Institute (NCI) | ||
| PubChem: | 176871 |
| ChEMBL: | CHEMBL1079742 |